Joseph Gaynor
Consigliere Generale presso Birla Carbon U.S.A., Inc.
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| John loudermilk | M | - |
Birla Carbon U.S.A., Inc.
 Birla Carbon U.S.A., Inc. Industrial SpecialtiesProcess Industries Birla Carbon U.S.A., Inc. manufactures carbon black additives for rubber, plastic, and liquid products. It offers rubber carbon black products for use in tires and mechanical rubber goods; and carbon specialty black products. The company was founded on 1922 and is headquartered in Marietta, GA. | - |
| Kumar Mangalam Birla | M | 57 |
Birla Carbon U.S.A., Inc.
Birla Carbon U.S.A., Inc. Industrial SpecialtiesProcess Industries Birla Carbon U.S.A., Inc. manufactures carbon black additives for rubber, plastic, and liquid products. It offers rubber carbon black products for use in tires and mechanical rubber goods; and carbon specialty black products. The company was founded on 1922 and is headquartered in Marietta, GA. | - |
| Ronaldo Silva Duarte | M | - |
Birla Carbon U.S.A., Inc.
Birla Carbon U.S.A., Inc. Industrial SpecialtiesProcess Industries Birla Carbon U.S.A., Inc. manufactures carbon black additives for rubber, plastic, and liquid products. It offers rubber carbon black products for use in tires and mechanical rubber goods; and carbon specialty black products. The company was founded on 1922 and is headquartered in Marietta, GA. | - |
| Timothy Fedrigon | M | - |
Birla Carbon U.S.A., Inc.
Birla Carbon U.S.A., Inc. Industrial SpecialtiesProcess Industries Birla Carbon U.S.A., Inc. manufactures carbon black additives for rubber, plastic, and liquid products. It offers rubber carbon black products for use in tires and mechanical rubber goods; and carbon specialty black products. The company was founded on 1922 and is headquartered in Marietta, GA. | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Charles Deignan | M | 59 |
AtheroGenics, Inc.
 AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | 10 anni |
| Russell Medford | M | 69 |
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | 16 anni |
| Mark P. Colonnese | M | 68 |
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | 10 anni |
| R. Wayne Alexander | M | 83 |
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | 16 anni |
| Robert Scott | M | 70 |
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | 6 anni |
| Mitchell Glass | M | - |
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | 5 anni |
| Kevin R. Boyle | M | - |
Birla Carbon U.S.A., Inc.
Birla Carbon U.S.A., Inc. Industrial SpecialtiesProcess Industries Birla Carbon U.S.A., Inc. manufactures carbon black additives for rubber, plastic, and liquid products. It offers rubber carbon black products for use in tires and mechanical rubber goods; and carbon specialty black products. The company was founded on 1922 and is headquartered in Marietta, GA. | - |
| Samuel Barker | M | 81 |
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | 4 anni |
| Thomas Keneth Baldwin | M | 58 |
Lanier Worldwide, Inc.
 Lanier Worldwide, Inc. Information Technology ServicesTechnology Services Lanier Worldwide, Inc. provides computer based document management solutions to local & national organizations. It offers printers & solutions. The company was founded in 1934 and is headquartered in Atlanta, GA. | 15 anni |
| Bret R. Osborn | M | 59 |
Lanier Worldwide, Inc.
Lanier Worldwide, Inc. Information Technology ServicesTechnology Services Lanier Worldwide, Inc. provides computer based document management solutions to local & national organizations. It offers printers & solutions. The company was founded in 1934 and is headquartered in Atlanta, GA. | 6 anni |
| Brian Blakey | M | 61 |
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | 4 anni |
| J. Christopher Prue | M | - |
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | - |
| Garratt W. Ponder | M | - |
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | - |
| Cynthia L. Sundell | M | - |
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | 14 anni |
| James A. Sikorski | M | - |
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | 8 anni |
| Charles Kunsch | M | - |
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | 12 anni |
| Ross Raymond | M | - |
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | - |
| Lilian Stern | F | - |
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | - |
| Teodoro Forcht-Dagi | M | 75 |
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | 9 anni |
| Donna L. Glasky | F | - |
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | - |
| G. John Mohr | M | - |
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | - |
| Martin A. Wasserman | M | - |
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | - |
| William A. Scott | M | 84 |
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | 12 anni |
| Mike A. Henos | M | 75 |
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | 15 anni |
| Michael McGovern | M | 72 |
Birla Carbon U.S.A., Inc.
Birla Carbon U.S.A., Inc. Industrial SpecialtiesProcess Industries Birla Carbon U.S.A., Inc. manufactures carbon black additives for rubber, plastic, and liquid products. It offers rubber carbon black products for use in tires and mechanical rubber goods; and carbon specialty black products. The company was founded on 1922 and is headquartered in Marietta, GA. | 1 anni |
| Vaughn D. Bryson | M | 85 |
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | 8 anni |
| Art Pappas | M | 76 |
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | 10 anni |
| David Bearman | M | 78 |
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | 6 anni |
| Suellyn P. Tornay | F | 63 |
Powell Goldstein Frazer & Murphy
| 2 anni |
| William Charles Montgomery | M | 77 |
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | 5 anni |
| Margaret E. Grayson | F | 77 |
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | 3 anni |
| Alan Scrivner | M | - |
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | 6 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 36 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Joseph Gaynor
- Contatti personali
